Bigul

Adline Chem Lab Ltd - 524604 - Closure of Trading Window

Pursuant to BSE's Circular No. LIST/COMP/01/2019-20 dated 2nd April, 2019 and as per Clause 4 of the Schedule B and other applicable regulations of SEBI (Prohibition of Insider Trading) Regulations, 2015, this is to inform you that in terms of Company's Code of Conduct for Prevention of Insider Trading the Trading Window of the Company will remain closed with effect from 1st July, 2023 till 48 hours after the declaration of Unaudited Financial Results for the quarter ended on 30th June, 2023.
27-06-2023
Bigul

Adline Chem Lab Ltd - 524604 - Non Applicability Of Submission Of Related Party Transaction Disclosure In XBRL Mode Under Reg. 23(9) For The Period Ended March 31, 2023

Please note that as per Regulation 15(2) of SEBI (LODR) Regulations, 2015, the provisions of Regulation 23 of SEBI (LODR) Regulations, 2015 are not applicable to the Company for the financial year 2022-23 as the paid up share capital of the Company as at 31st March, 2022 was Rs. 5.85 Crore and the Net worth of the Company as at 31st March, 2022 was Rs. 2.65 Crore. Hence, the Company had not exceeded the prescribed threshold limits for applicability of provisions of Regulation 23 of SEBI (LODR) Regulations, 2015 for the year 2022-23. Hence the Company is not required to submit disclosure of Related Party Transaction in XBRL Mode as required under Regulation 23(9) of SEBI LODR for the Period ended March 31, 2023.
07-06-2023
Bigul

Adline Chem Lab Ltd - 524604 - Draft Letter of Offer

Kunvarji Finstock Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer to the public shareholders of Adline Chem Lab Ltd ("Target Company").
31-05-2023
Bigul

Adline Chem Lab Ltd - 524604 - Results- Financial Results For March 31, 2023

Please note that the Board of Directors in their meeting held today i.e. on 30th May, 2023, have approved the Audited Financial Results for the financial year 2022-23 ended on 31st March, 2023. Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, we are enclosing herewith: 1. Statement of Audited Financial Results for the year ended on 31st March, 2023. 2. Auditors' Report on the Audited Financial Results 3. Declaration to the effect that there is Unmodified Opinion with respect to Audited Financial Results for the year ended on 31st March, 2023
30-05-2023
Bigul

Adline Chem Lab Ltd - 524604 - Board Meeting Outcome for Outcome Of Board Meeting And Submission Of Audited Financial Results For The Year Ended On 31St March, 2023

Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, we are enclosing herewith: 1. Statement of Audited Financial Results for the year ended on 31st March, 2023. 2. Auditors' Report on the Audited Financial Results 3. Declaration to the effect that there is Unmodified Opinion with respect to Audited Financial Results for the year ended on 31st March, 2023
30-05-2023
Bigul

Adline Chem Lab Ltd - 524604 - Detailed Public Statement

Kunvarji Finstock Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Detailed Public Statement in terms of Regulations 13(4), 14(3) and 15(2) and other applicable regulations of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) regulations, 2011, and subsequent amendments thereof, for the attention of the public shareholders of Adline Chem Lab Ltd ("Target Company").
24-05-2023
Bigul

Adline Chem Lab Ltd - 524604 - Open Offer

Kunvarji Finstock Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Public Announcement under regulation 3(1) and 4 read with regulation 13, 14 and 15(1) and other applicable provisions of The Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) regulations, 2011, as amended thereof, for the attention of the eligible Shareholders of Adline Chem Lab Ltd ("Target Company").
18-05-2023
Bigul

Adline Chem Lab Ltd - 524604 - Update on board meeting

Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve We wish to inform you that the next Meeting of the Board of Directors of the Company to consider and approve the Standalone Audited Financial Results of the Company for the Financial Year 2022 23 ended on 31st March, 2023 is scheduled to be held on 30th May, 2023.
16-05-2023
Bigul

Adline Chem Lab Ltd - 524604 - Board Meeting Intimation for Consideration Of Standalone Audited Financial Results For The Financial Year 2022-23 Ended On 31St March, 2023

Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve the Standalone Audited Financial Results of the Company for the Financial Year 2022 23 ended on 31st March, 2023
16-05-2023
Next Page
Close

Let's Open Free Demat Account